Company Profile
Hanmi Pharm. Co., Ltd., a biopharmaceutical company provides the manufacture and sale of pharmaceutical products globally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases.
The company's products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. Founded in 1973, the company is based in Hwaseong-si, South Korea.